Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are a class of drugs that inhibit NAMPT, a rate-limiting enzyme in the mammalian NAD+ salvage pathway. NAMPTs plays an important role in cancer cell survival, proliferation and resistance to chemotherapy. Inhibiting NAMPT could potentially halt cancer progression.

The NAMPT Inhibitors Market has seen increased interest from pharma companies looking to develop novel cancer therapeutics.



The NAMPT inhibitors market is estimated to be valued at USD 1.5 Bn in 2024 and is expected to reach USD 3.5 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031

Key players operating in the NAMPT inhibitors market are Chroma Therapeutics, Calithera Biosciences, Taiho Pharmaceutical and Rafael Pharmaceuticals.

Key players like Chroma Therapeutics and Calithera Biosciences are conducting clinical trials of their NAMPT inhibitor drug candidates for various cancer indications like renal cell carcinoma, triple negative breast cancer and hematological malignancies. Positive results from these trials can boost the adoption of NAMPT inhibitors in cancer treatment.



The growing prevalence of cancer worldwide presents a massive commercial opportunity for NAMPT inhibitor drugs. As per WHO, cancer burden is expected to surge to 29.5 million new cases by 2040. This rising cancer incidence rate will drive the demand for novel targeted therapies like NAMPT inhibitors.



Expanding into new international markets will allow companies to tap into large cancer patient pools and boost sales volumes. Regional collaborations and licensing deals can help established players strengthen their global presence.



The key driver fueling the NAMPT inhibitors market growth is the rising prevalence of cancer globally. According to WHO, cancer is the second leading cause of death worldwide and was responsible for nearly 10 million deaths in 2020. The increasing cancer burden, coupled with the lack of effective treatment options for many cancer types, provides a fertile ground for novel therapies like NAMPT inhibitors to grow.

PEST Analysis

Political: Changes in patent laws can impact the development of new NAMPT inhibitors drugs. Governments provide funding for research programs aimed at developing new treatment options.

Economic: Overall economic growth influences healthcare spending which drives demand for new drugs. Potential price controls can affect profit margins of companies.

Social: Rising health consciousness and increasing adoption of healthy lifestyles is driving demand for drugs that treat metabolic disorders. Population growth and aging trends also affect market potential.

Technological: Advancements in drug delivery mechanisms, biomarkers and high throughput screening methods allow for rapid identification of new drug candidates. Adoption of digital technologies helps improve access to care.



Geographical regions with high market value

North America currently accounts for the largest share of the global NAMPT inhibitors market in terms of value. This can be attributed to the concentration of major players, higher adoption of new drugs, rising prevalence of target diseases and greater healthcare spending in the region. Growing geriatric population, availability of reimbursement and well-established regulatory framework further support market growth.



Fastest growing regional market

The Asia Pacific region is poised to witness the highest growth over the forecast period aided by growing population, increasing healthcare expenditure, rising prevalence of metabolic disorders due to shift towards sedentary lifestyles and development of new treatments. In addition, expansion of pharmaceutical industry and improving access to healthcare across developing countries creates a favorable environment for the market to expand.

About Author:                                                                                                                                                           

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)